Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Oskar Hemmingsson

Oskar Hemmingsson

Biträdande universitetslektor och överläkare med inriktning mot övre abdominell kirurgi. Driver klinisk och translationell cancerforskning och undervisar på läkarprogrammet.

Kontakt

E-post
oskar.hemmingsson@umu.se
Telefon
090-785 85 45, 070-719 75 48

Verksam vid

Anknytning
Universitetslektor, överläkare vid Institutionen för kirurgisk och perioperativ vetenskap Enhet: Kirurgi
Plats
1A 9 tr, Kirurgcentrum Kirurgcentrum, Norrlands universitetssjukhus, 901 85 Umeå
Anknytning
Anknuten som övrig/annan befattning till Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
Plats
Umeå universitet, 901 87 Umeå
LRIG1 is a conserved EGFR regulator involved in melanoma development, survival and treatment resistance
Oncogene, Springer Nature 2021, Vol. 40 : 3707-3718
Billing, Ola; Holmgren, Ylva; Nosek, Daniel; et al.
Survival and prognostic factors after transplantation, resection and ablation in a national cohort of early hepatocellular carcinoma
HPB, Elsevier 2021, Vol. 23, (3) : 394-403
Eilard, Malin S.; Naredi, Peter; Helmersson, Madeleine; et al.
Liver resection and ablation for squamous cell carcinoma liver metastases
BJS Open, Oxford University Press 2021, Vol. 5, (4)
Engstrand, J.; Abreu de Carvalho, L.F.; Aghayan, D.; et al.
Alternative redox forms of ASNA-1 separate insulin signaling from tail-anchored protein targeting and cisplatin resistance in C. elegans
Scientific Reports, Springer 2021, Vol. 11, (1)
Raj, Dorota; Billing, Ola; Podraza-Farhanieh, Agnieszka; et al.
Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial
Trials, BioMed Central 2021, Vol. 22, (1)
Yaqub, Sheraz; Bjørnbeth, Bjørn Atle; Angelsen, Jon-Helge; et al.
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma
Cancer Chemotherapy and Pharmacology
Öman, Mikael; Wettergren, Yvonne; Odin, Elisabeth; et al.
Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv
BJS Open, John Wiley & Sons 2020, Vol. 4, (1) : 109-117
Henriksson, M.; Bjornsson, B.; Sternby Eilard, M.; et al.
Regional variations in the treatment of gallstone disease may affect patient outcome: A large, population-based register study in sweden
Scandinavian Journal of Surgery
Lindqvist, Lisa; Sandblom, G.; Nordin, Pär; et al.
Quality-of-life after bile duct injury repaired by hepaticojejunostomy: a national cohort study
Scandinavian Journal of Gastroenterology, Taylor & Francis 2020, Vol. 55, (9) : 1087-1092
Sturesson, Christian; Hemmingsson, Oskar; Mansson, Christopher; et al.
Surgical treatment of breast cancer liver metastases: A nationwide registry-based case control study
European Journal of Surgical Oncology, Elsevier 2020, Vol. 46, (6) : 1006-1012
Sundén, Marcus; Hermansson, Cecilia; Taflin, Helena; et al.
Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study
Journal of Hepatology, Vol. 70, (5) : 885-892
Baumeister, Sebastian E.; Schlesinger, Sabrina; Aleksandrova, Krasimira; et al.
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
International Journal of Cancer, John Wiley & Sons 2019, Vol. 144, (5) : 957-966
Bradbury, Kathryn E.; Appleby, Paul N.; Tipper, Sarah J.; et al.
Post cholecystectomy bile duct injury: early, intermediate or late repair with hepaticojejunostomy - an E-AHPBA multi-center study
HPB, Elsevier 2019, Vol. 21, (12) : 1641-1647
Rystedt, Jenny M. L.; Kleeff, Joerg; Salvia, Roberto; et al.
Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, Vol. 140, (10) : 2246-2255
Caini, Saverio; Masala, Giovanna; Saieva, Calogero; et al.
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study
BMC Medicine, BioMed Central 2017, Vol. 72, (15)
Fedirko, Veronika; Tran, Hao Quang; Gewirtz, Andrew T; et al.
Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
Cancer Prevention Research, Vol. 9, (9) : 758-765
Duarte-Salles, Talita; Misra, Sandeep; Stepien, Magdalena; et al.
Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
American Journal of Clinical Nutrition, Vol. 104, (2) : 406-414
Hughes, David J.; Duarte-Salles, Talita; Hybsier, Sandra; et al.
Anterior Resection for Rectal Cancer and Visceral Blood Flow: An Explorative Study
Scandinavian Journal of Surgery, Vol. 105, (2) : 78-83
Rutegård, Martin; Hassmén, N; Hemmingsson, Oskar; et al.
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Nature, Vol. 513, (7516) : 105-109
Boussemart, Lise; Malka-Mahieu, Hélène; Girault, Isabelle; et al.
Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin
Worm, Landes Bioscience 2013, Vol. 2, (1)
Natarajan, Balasubramanian; Gaur, Rahul; Hemmingsson, Oskar; et al.
High tie in anterior resection for rectal cancer confers no increased risk of anastomotic leakage
British Journal of Surgery, Malden, MA: Wiley-Blackwell 2012, Vol. 99, (1) : 127-132
Rutegård, Martin; Hemmingsson, Oskar; Matthiessen, P.; et al.
ASNA1 and cisplatin resistance: studies in C. elegans and in human tumor cells
Umeå University medical dissertations, 1390
Hemmingsson, Oskar
ASNA-1 activity modulates sensitivity to cisplatin
Cancer Research, American Association for Cancer Research 2010, Vol. 70, (24) : 10321-10328
Hemmingsson, Oskar; Kao, Gautam; Still, Maria; et al.
Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1
Oncology Reports, Spandidos Publications 2009, Vol. 22, (4) : 869-875
Hemmingsson, Oskar; Nöjd, Mikael; Kao, Gautam; et al.
ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite
Cancer Chemotherapy and Pharmacology, Springer 2009, Vol. 63, (3) : 491-499
Hemmingsson, Oskar; Zhang, Youyi; Still, Maria; et al.
­ASNA-1 influence on apoptosis in C. elegans
Kao, Gautam; Hemmingsson, Oskar; Chitturi, Jyothsna; et al.
Unfolded protein response and enpl-1 depletion sensitize C. elegans to the anti-cancer drug cisplatin
Natarajan, Balasubramanian; Hemmingsson, Oskar; Kao, Gautam; et al.
Visa publikationer i DiVA

Forskningsprojekt

1 januari 2020 till 31 december 2029
The BRECLIM trial
1 januari 2013
Cancerforskning (PI Hemmingsson)
Masken C Elegans – en elegant cancermodell?

Oskar Hemmingsson föreläste om hur masken C Elegans kan användas som en elegant cancermodell i forskningen.